In postmenopausal women diagnosed with breast cancer, is an aromatase inhibitor or estrogen receptor modulator associated with better outcomes?

Authors

Lynn M. Wilson DO, Lehigh Valley Health NetworkFollow
Faris Albakaa MD, Lehigh Valley Health NetworkFollow
Susan E. Hansen MA, Lehigh Valley Health NetworkFollow

Publication/Presentation Date

2-2023

Volume

26

Issue

2

First Page

31

Last Page

33

Published In/Presented At

Wilson, Lynn Marie MD; Albakoaa, Faris MD; Hansen, Susan E MA. In postmenopausal women diagnosed with breast cancer, is an aromatase inhibitor or estrogen receptor modulator associated with better outcomes?. Evidence-Based Practice 26(2):p 31-33, February 2023. | DOI: 10.1097/EBP.0000000000001747

Disciplines

Medicine and Health Sciences

Department(s)

Department of Family Medicine, Department of Family Medicine Faculty, Department of Family Medicine Residents, Network Office of Research and Innovation

Document Type

Article